Results 91 to 100 of about 1,506 (115)

Pharmacological considerations for prescribing of small molecule inhibitors in patients with non-small cell lung cancer. [PDF]

EClinicalMedicine
Hulskotte LMG, Veerman GDM, Lanser DAC, Reyners AKL, van Schaik RHN, Dingemans AC, Taxis K, Mathijssen RHJ, Jansman FGA.   +8 more
europepmc   +1 more source

Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study. [PDF]

Biomark Res
Lu C, Xu CR, Zhang YC, Ke EE, Sun YL, Bai XY, Chen ZH, Su J, Deng Y, Hou T, Zhao F, Li M, Wang BC, Tu HY, Wang Z, Zhang XC, Chen HJ, Yang JJ, Zhong WZ, Zhou Q, Wu YL.   +20 more
europepmc   +1 more source

<i>RET</i> Gene Alterations in Clinical Practice: A Comprehensive Review and Database Update. [PDF]

Genes (Basel)
Ricciardi Tenore C, Tulli E, Perrucci A, Bertozzi R, Fortuna L, Maneri G, Santonocito C, Urbani A, De Bonis M, Minucci A.   +9 more
europepmc   +1 more source

Ectopic ACTH Production in Medullary Thyroid Carcinoma-A Study of Two Cases. [PDF]

Case Rep Endocrinol
Bränström R, Hedberg F, Huisman M, Petersson M, Jerning C, Shabo I, Goldstein DJM, Larsson M, Juhlin CC.   +8 more
europepmc   +1 more source

Modern therapeutic approaches in cholangiocarcinoma: A narrative review of key biomarkers and clinical trials. [PDF]

Transl Oncol
Almeida A, Manzi J, Hoff C, Kadri H, Livingstone A, Gleisner A, Toegel EB, Schulick R, Hoff PM, Vianna R, Abreu P.   +10 more
europepmc   +1 more source

Kinase Plasticity with Vandetanib Treatment Enhances Sensitivity to Tamoxifen in Estrogen Receptor Positive Breast Cancer. [PDF]

Mol Cancer Ther
Whitman AA, Kakati RT, Haase S, Thai CH, Tripathi SK, Szenasi AT, Brunk EC, Okumu DO, East MP, Molina SG, Beltran AS, Raab JR, Carey LA, Perou CM, Johnson GL, Spanheimer PM.   +15 more
europepmc   +1 more source

How to manage medullary thyroid carcinoma: current treatment strategies. [PDF]

Drugs Context
Saltiki K, Karapanou O, Michalaki M, Effraimidis G.   +3 more
europepmc   +1 more source

Case Report: Complete pathologic response to neoadjuvant immunotherapy-chemotherapy in a patient with RET fusion-positive non-small cell lung cancer. [PDF]

Front Oncol
Wang Y, Zhang Y, Cai C, Liu X, Ren S, Zhou S.   +5 more
europepmc   +1 more source

Clinical Activity of RET TKI Plus Chemotherapy After Progression on a RET TKI in a <i>RET</i> Fusion-Positive NSCLC Real-World Cohort: A Brief Report. [PDF]

JTO Clin Res Rep
Paula AG, Liu X, Karimi A, Concannon K, Heeke S, Elamin YY, Wang K, Pozadzides JV, Vokes N, Tu J, Tsao A, Negrao MV, Zhang J, Singhi EK, Zhang B, Rinsurongkawong W, Martins IG, Tran HT, Gibbons DL, Nilsson MB, Heymach JV.   +20 more
europepmc   +1 more source

Pan-cancer clinicopathological and genomic characteristics of peritoneal metastasis. [PDF]

NPJ Precis Oncol
Chen T, Yang Y, Liu X, Dong F, Wang L, Shan Y, Wang X.   +6 more
europepmc   +1 more source